Genetically Determined Telomere Length in Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma Risk and Outcome

Overview

Journal Blood Cancer J

Date 2024 Nov 11

PMID 39528488

Authors

Matteo Giaccherini

Alyssa I Clay-Gilmour

Romano Liotti

Angelica Macauda

Manuel Gentiluomo

Elizabeth E Brown

Mitchell J Machiela

Stephen J Chanock

Michelle A T Hildebrandt

Aaron D Norman

Elisabet Manasanch

S Vincent Rajkumar

Jonathan N Hofmann

Sonja I Berndt

Parveen Bhatti

Graham G Giles

Elad Ziv

Shaji K Kumar

Nicola J Camp

Wendy Cozen

Susan L Slager

Federico Canzian

Federica Gemignani

Celine M Vachon

Daniele Campa

Affiliations

Soon will be listed here.

References

Campa D, Martino A, Varkonyi J, Lesueur F, Jamroziak K, Landi S . Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer. 2014; 136(5):E351-8. DOI: 10.1002/ijc.29101. View

Giaccherini M, Macauda A, Sgherza N, Sainz J, Gemignani F, Maldonado J . Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms. Blood Cancer J. 2020; 10(8):89. PMC: 7463014. DOI: 10.1038/s41408-020-00356-5. View

Rajkumar S, Kyle R, Therneau T, Melton 3rd L, Bradwell A, Clark R . Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005; 106(3):812-7. PMC: 1895159. DOI: 10.1182/blood-2005-03-1038. View

Giaccherini M, Macauda A, Orciuolo E, Rymko M, Gruenpeter K, Dumontet C . Genetically determined telomere length and multiple myeloma risk and outcome. Blood Cancer J. 2021; 11(4):74. PMC: 8046773. DOI: 10.1038/s41408-021-00462-y. View

Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S . Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021; 53(10):1425-1433. PMC: 8492471. DOI: 10.1038/s41588-021-00944-6. View

Aviv A, Anderson J, Shay J . Mutations, Cancer and the Telomere Length Paradox. Trends Cancer. 2017; 3(4):253-258. PMC: 5903276. DOI: 10.1016/j.trecan.2017.02.005. View

Xu X, Qu K, Pang Q, Wang Z, Zhou Y, Liu C . Association between telomere length and survival in cancer patients: a meta-analysis and review of literature. Front Med. 2016; 10(2):191-203. DOI: 10.1007/s11684-016-0450-2. View

Clay-Gilmour A, Hildebrandt M, Brown E, Hofmann J, Spinelli J, Giles G . Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance. Blood Adv. 2020; 4(12):2789-2797. PMC: 7322948. DOI: 10.1182/bloodadvances.2020001435. View

Hosnijeh F, Matullo G, Russo A, Guarrera S, Modica F, Nieters A . Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study. Int J Cancer. 2014; 135(12):2910-7. DOI: 10.1002/ijc.28934. View

10.

Kumar S, Rajkumar V, Kyle R, van Duin M, Sonneveld P, Mateos M . Multiple myeloma. Nat Rev Dis Primers. 2017; 3:17046. DOI: 10.1038/nrdp.2017.46. View

11.

Giaccherini M, Gentiluomo M, Fornili M, Lucenteforte E, Baglietto L, Campa D . Association between telomere length and mitochondrial copy number and cancer risk in humans: A meta-analysis on more than 300,000 individuals. Crit Rev Oncol Hematol. 2021; 167:103510. DOI: 10.1016/j.critrevonc.2021.103510. View

12.

Nakao T, Bick A, Taub M, Zekavat S, Uddin M, Niroula A . Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential. Sci Adv. 2022; 8(14):eabl6579. PMC: 8986098. DOI: 10.1126/sciadv.abl6579. View